In The News: You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials
Launching clinical trials is complex. Early-stage biotech's often lack the sourcing expertise needed to select CROs, manage contracts, and control costs. Without a structured approach, inefficiencies and risks can derail progress.
This article highlights common pitfalls and shows how early involvement of sourcing professionals can streamline operations, improve oversight, and protect your investment.
Read more